Shares of UNI MEDICAL (02666) surged 5.07% in intraday trading following the release of its impressive interim results for the first half of 2025. The company's strong financial performance and expansion in healthcare services have clearly resonated with investors.

According to the interim report, UNI MEDICAL recorded a revenue of RMB 7.581 billion for the six months ended June 30, 2025, representing a substantial year-on-year increase of 15.9%. The profit attributable to ordinary equity holders reached approximately RMB 1.228 billion, up 8% compared to the same period last year. Basic earnings per share stood at RMB 0.65, further underlining the company's robust financial health.

The positive market reaction can be attributed to UNI MEDICAL's expanding operational footprint and diversified business model. As of June 30, 2025, the group operated 68 comprehensive and specialty medical institutions, providing quality medical services to the public. Additionally, the company has been actively engaged in healthcare technology businesses, including medical equipment lifecycle management and smart healthcare services. UNI MEDICAL also offers comprehensive financial solutions centered on financial leasing services, demonstrating its commitment to innovation and growth in the healthcare sector.